Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New AI Software Accurately Detects Lung Cancers on X-Rays and Cuts Unnecessary Chest CT Scans by 30%

By HospiMedica International staff writers
Posted on 06 Aug 2021
A recent study has shown that a deep learning-based artificial intelligence (AI) algorithm can improve the performance of readers in detecting lung cancers on chest radiographs.

According to the second joint study conducted by Massachusetts General Hospital (Boston, MA, USA) and Lunit Inc. More...
(Seoul, Korea), AI had 28% sensitivity benefit for radiology residents, helping them properly recommend CT exams for potential lung cancer patients, and 30% specificity benefit for radiologists in lung cancer detection, reducing unnecessary CT exams. The joint research team has previously focused on validating the accuracy of AI, and proved that Lunit INSIGHT CXR, an AI software for analyzing chest X-rays, can accurately detect malignant pulmonary nodules, which can cause lung cancer. In this consecutive study, the team focused on whether AI can affect the performance of medical professionals in finding lung cancers.

For the study, 519 images of cancer-positive and cancer-negative patients were selected from the National Lung Screening Trial (NLST). Eight readers, including three radiology residents and five board-certified radiologists, participated in the reading. By comparing the analysis of the readers and Lunit INSIGHT CXR, the result showed that AI could lead to more efficient and precise diagnosis for both doctors and patients. With AI, radiology residents were able to recommend 28% more chest CT examinations for patients who may have potential risk of lung cancer. Also, radiologists recommended about 30% lesser proportion of unnecessary chest CT examinations in cancer-negative patients.

"The use of AI could help to detect pulmonary nodules accurately with chest X-rays, as well as reduce the need for unnecessary chest CT exams in some patients," said Mannudeep K. Kalra, MD, a radiologist at the MGH and Co-investigator on the study. "This finding can benefit patients by enabling them to avoid unneeded radiation exposure, and it can benefit the healthcare system by preventing certain medical costs."

"Chest X-ray is the firsthand diagnostic tool to detect lung cancer, but it has limitations as it is a compressed 2D rendering of 3D human structures," said Brandon Suh, CEO of Lunit. "An accurate analysis through Lunit INSIGHT CXR can help medical professionals provide diagnosis to patients with increased efficiency - preventing potential cancer at an early stage, while saving time and cost for those who do not need a further examination."

Related Links:

Massachusetts General Hospital
Lunit Inc.



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.